ZYBERNO
Stock Report
Updated Sep 1, 2026

AIBOTICS, INC. (AIBT)

Healthcare • OTC

$0.00

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
7.0/100
POOR BUSINESS
AIBOTICS, INC. (AIBT) scores 7/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-409.9%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

AIBOTICS, INC. (AIBT) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.00
Market Cap:$216.75K

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$608.19K

Price Action & Momentum (1)

% of 52-Week High:4.1%
B. Profitability Assessment

Return Metrics (4)

ROA:-260.6%
Reinvestment Rate:0.0%
Fundamental Growth Rate (g):0.0%

Margin Analysis (1)

Ebitda Margin:-79,145.9%

Yield Metrics (2)

Earnings Yield:-$10.00K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.05x
Quick Ratio:0.05x
Cash Ratio:0.05x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-9.20x
Times Interest Earned:-9.20

Capital Structure (4)

Working Capital:-4,875,875.00
Cash And Cash Equivalents:233,427.00
Long Term Debt:$0.00
Net Debt:$391.44K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$2.18K
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$2.18K-$1.73M

Bottom Line Performance (3)

-$2.09M
Income Before Tax:-$2.09M
Ebitda Ttm:-1,727,756.00

Operating Expenses (5)

Operating Expenses:1,727,756.00
R And D Expense:0.00
Sga Expense:1,727,756.00
Income Tax Expense:$0.00
Interest Expense:200,458.00

Expense Ratios (1)

Ebitda Margin:-79,145.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$549.59K
Current Assets:$275.62K
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$775.55K

Liability Structure (4)

Total Liabilities:5,151,494.00
Current Liabilities:5,151,494.00
Long Term Debt:$0.00
Short Term Debt:$624.87K

Equity & Capital (3)

Equity:-$4.60M
Retained Earnings:-$13.98M
Common Stock:7,500,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:40,525.00
Accounts Payable:624,868.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:-43,750.00
C. Cash Flow Analysis

Operating Activities (2)

-$466.14K$0.00

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$69.18K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:279,083.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.04
-$0.04
Earnings Per Share Ttm:-$0.00

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.00

Book Value & Capital (2)

Book Value Per Share:-$0.01
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.00x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:0.05x
Days Inventory Outstanding Ttm:6,775.82

Payables & Cash Cycle (2)

Days Payable Outstanding:104,478.62
Cash Conversion Cycle:-98,701.79
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:0.0%
Fundamental Growth Rate (g):0.0%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:AIBT
Company Name:AIBOTICS, INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:722.51M
Shares Outstanding Basic:722.51M
Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 22:57:55 UTC
Data Timestamp:2026-08-22T19:07:37.708344
Scroll to Top